Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials.
The Journal of dermatological treatment·2020
DHHC21 is a STIM1 protein S-acyltransferase that modulates immune function in vivo.
Journal of cell science·2026
The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability.
Biochimica et biophysica acta. Reviews on cancer·2026